pharmaphorum

DECEMBER 9, 2020

COVID-19’s knock-on effect on cancer patients is of concern by HCPs, with delayed or decreased diagnosis seen as a key worry. CREATION.co’s Lara Meyer explores why HCPs need more support. The COVID-19 pandemic has been mainstream headline news throughout 2020 and continues to have a profound impact on all our lives. A key concern that has emerged from the crisis is how COVID-19 will affect other areas of healthcare, particularly cancer diagnosis and treatment.

Hospitals 124

Hospitals Clinic Management Pharmaceutical Companies Pharmaceutical Companies 124

Outsourcing Pharma

DECEMBER 8, 2020

An expert from the clinical research technology specialist discusses how trial teams can use real-world evidence to improve study inclusivity.

119

119

Druggist

DECEMBER 9, 2020

Several factors can cause skin itchiness (also known as pruritus). Skin itch is commonly associated with eczema (dermatitis), psoriasis, chickenpox, insect bites, hives and other conditions. Several effective creams to stop itching can be purchased from supermarkets, pharmacies and online. Sale of some anti-itch creams is restricted to pharmacies only.

Compounding 97

Compounding People Management 97

Pharma Times

DECEMBER 9, 2020

ZUMA-12 phase II study is evaluating therapy as a first-line treatment for high-risk large B-cell lymphoma

60

60

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

pharmaphorum

DECEMBER 11, 2020

Embedding diversity into clinical research does not start and end at trial recruitment – the community needs processes and institutions that reflect society and provide representation. Greater representation among study designers, research teams, and funding committees would lead to greater diversity among research participants and help to tackle health inequalities.

Vaccines 116

Vaccines 116

Outsourcing Pharma

DECEMBER 10, 2020

Health Decisions and OncoBay Clinical will collaborate on specialized clinical development services addressing therapies for womenâs cancers.

82

82

Pharma Times

DECEMBER 9, 2020

'Encouraging' data for investigational candidates across a range of blood cancers

59

59

pharmaphorum

DECEMBER 9, 2020

Reviewers from the FDA have given their blessing to the Pfizer/BioNTech COVID-19 vaccine ahead of a key meeting tomorrow – but the regulator noted that there are still uncertainties about whether the shot can stop the disease from spreading. The gist of a briefing document published from FDA reviewers ahead of an expert advisory board meeting is that the vaccine is good to go.

Vaccines 111

Vaccines FDA Adverse Reactions Documentation 111

Outsourcing Pharma

DECEMBER 7, 2020

A leader from data-centric CRO Quanticate shares perspective on how the pandemic has disrupted trials, and what tools and technologies can keep work going.

72

72

Pharma Marketing Network

DECEMBER 7, 2020

Tune in now to listen to Darshan Talks Podcast, What a Clinical Trial Transparency Program Is (and Why You Need One). The post What a Clinical Trial Transparency Program Is (and Why You Need One) appeared first on Pharma Marketing Network.

59

59

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

DECEMBER 10, 2020

Updated guidance warns people with a history of allergic reactions not to receive the shot

58

58

pharmaphorum

DECEMBER 9, 2020

Sanofi and Regeneron’s Dupixent has had the US market for the treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) mainly to itself since June 2019, but GlaxoSmithKline’s Nucala is now breathing down its neck. The FDA has started its review of Nucala (mepolizumab) for the inflammatory condition, which results in the growth of nasal polyps in the nose that can obstruct airflow and cause mucus discharge, sometimes requiring surgical intervention.

FDA 111

FDA 111

Outsourcing Pharma

DECEMBER 10, 2020

The companyâs cancer drug, devimistat, has received orphan status from the agency for treating clear-cell sarcoma, pancreatic cancer, and other diseases.

FDA 71

FDA 71

Pharma Mirror

DECEMBER 10, 2020

Terrassa (Barcelona) 2020. The Telstar subsidiary in Dhaka, Bangladesh, has relocated to a new installation reacting to the ongoing growth of demand for Life Sciences service & product solutions in the region. Under the leadership of Parvez Hashim, Country General Manager, Telstar’s office has consolidated a professional and specialized service in Asia’s pharmaceutical market in consultancy, engineering, construction and manufacturing processes for development of turnkey plants and installat

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Pharma Times

DECEMBER 9, 2020

Meet the winners of the 2020 PharmaTimes Marketer of the Year, Communications Awards and Sales Awards

Communication 58

Communication 58

pharmaphorum

DECEMBER 7, 2020

Bureaucracy, political upheaval, and lack of regulations continue to make Latin America a difficult market for European and North American pharma to enter – and COVID-19 has only worsened these issues. Developing market specialist Dr Zulf Masters OBE takes us through the nuances of being successful in this region. Having worked all around the world to supply medicines to developing markets, Dr Zulf Masters understands the biggest barrier for a pharma company entering these regions is a lack of u

FDA 109

FDA Pharmaceutical Companies Pharmaceutical Companies Hospitals 109

Outsourcing Pharma

DECEMBER 10, 2020

Through organizations like the Association of Clinical Research Organizations, clinical research professionals are helping decentralized research evolve.

70

70

That Frugal Pharmacist

DECEMBER 9, 2020

I’m That Frugal Pharmacist, so clearly I should have some ideas about frugal living, right? 2020 has been a heck of a year for everyone. I’ve got two big tips to either make the most of your frugal muscle, or make some smart money moves and start maximizing your money. Clearly, you should be tracking … Frugal Living?

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharma Times

DECEMBER 8, 2020

A 90 year-old woman in Coventry has become the first person in the UK to be given the vaccine

Vaccines 55

Vaccines 55

pharmaphorum

DECEMBER 10, 2020

The US government’s coronavirus vaccine chief has said that Pfizer/BioNTech’s vaccine could carry a warning that it should be avoided by people who are prone to serious allergic reactions. Moncef Slaoui, co-head of the US government’s Operation Warp Speed COVID-19 vaccine programme, made the comments after the UK drugs regulator advised those with severe allergies to avoid the vaccine.

Vaccines 103

Vaccines Documentation FDA 103

Outsourcing Pharma

DECEMBER 7, 2020

The online DNA network has delved into self-reported data of more than 563,000 US adults to help identify genetic risk of infection and severe outcomes.

63

63

Pharma Mirror

DECEMBER 9, 2020

Ormond Beach, FL – CO2Meter, Inc. has partnered with a national pharmacy chain to keep their customers and employees safe from the potential hazardous effects for CO2 exposure from the dry ice that is keeping the COVID-19 vaccines cold. A national pharmacy chain contacted CO2Meter on December 1st asking about devices to detect the release of CO2 when dry ice sublimates.

Vaccines 52

Vaccines 52

Pharma Times

DECEMBER 9, 2020

Agreement will utilise RetinAI's IT solutions and artificial intelligence tools to support projects in ophthalmology

54

54

pharmaphorum

DECEMBER 7, 2020

Tuesday has been dubbed “V-day” in the UK, when the first doses of Pfizer/BioNTech’s coronavirus vaccine will be distributed to the public outside of a clinical trial. Health secretary Matt Hancock reportedly came up with the wartime analogy to describe what will be the largest scale vaccination programme in the country’s history. The UK last week became the first country in the world to officially authorise the vaccine, which has so far shown an effectiveness of around 95% and minimal side effe

Vaccines 100

Vaccines 100

Outsourcing Pharma

DECEMBER 9, 2020

The agency continues to offer advice, resources and oversight during the pandemic to help develop tests, treatments and other solutions for the virus.

FDA 52

FDA 52

Pharma Marketing Network

DECEMBER 9, 2020

REGISTER NOW! The post Biotech Showcase | January 11-15, 2021 | Digital Event appeared first on Pharma Marketing Network.

52

52

Pharma Times

DECEMBER 8, 2020

The charity is slashing £45 million from its research budget

53

53

pharmaphorum

DECEMBER 10, 2020

UK digital health firm Sensyne has secured access to millions more anonymised patent records via an alliance with US clinical trial data specialist Phesi. The new agreement comes after a string of access deals with NHS trusts for patient data, and coincides with a bid by Sensyne to raise £27.5 million (around $37 million) through a 90 pence per share placing.

98

98

indispensable health

DECEMBER 8, 2020

What are good Characteristics of a pharmacy partner for an Ambulatory Surgery Center? When considering what characteristics an Ambulatory Surgery Center (ASC) should consider in a pharmacy partner “flexibility” is the first that comes to mind. Ambulatory Surgery Centers require a pharmacy partner that can be flexible to their unique situations. Every ASC has various needs and pharmacy providers must be able to provide custom services tailored to fit the outpatient surgery center’s needs.

Pharmacy Service Companies 52

Pharmacy Service Companies Controlled Substances Customer Service Documentation 52

Outsourcing Pharma

DECEMBER 8, 2020

The industry analysis dives into likely developments in supply chain, impact of the new White House occupant, CDMO growth and other key areas.

52

52

Pharma Times

DECEMBER 10, 2020

Submission is based on data from the pivotal SYNAPSE study

FDA 52

FDA 52

pharmaphorum

DECEMBER 8, 2020

A new Health Union survey reveals that people with chronic conditions feel that telehealth, despite its convenience and increased use throughout the COVID-19 pandemic, is generally less preferable than in-person visits, but can still serve as an occasionally suitable alternative. The survey is the fifth in Health Union’s ongoing COVID-19 Consumer Attitudes and Health Behaviors Survey series that captures “snapshots in time” that track the perspectives and health behaviors of people with chronic

98

98

Pharma Marketing Network

DECEMBER 7, 2020

Tune in now to listen to Darshan Talks Podcast, Is Off-Label Marketing by a Pharma Company a Bad Thing? The post Is Off-Label Marketing by a Pharma Company a Bad Thing? appeared first on Pharma Marketing Network.

Labelling 49

Labelling 49